Spenda Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Spenda şirketinin toplam hissedar öz sermayesi A$34.5M ve toplam borcu A$13.4M olup, bu da borç-öz sermaye oranını 38.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$51.0M ve A$16.5M dir.

Anahtar bilgiler

38.8%

Borç/özkaynak oranı

AU$13.38m

Borç

Faiz karşılama oranı	n/a
Nakit	AU$9.84m
Eşitlik	AU$34.50m
Toplam yükümlülükler	AU$16.54m
Toplam varlıklar	AU$51.05m

Son finansal sağlık güncellemeleri

Recent updates

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

Apr 12

Spenda (ASX:SPX) Is Using Debt Safely

Dec 02

Is Spenda (ASX:SPX) A Risky Investment?

Jun 20

Is Spenda (ASX:SPX) Using Too Much Debt?

Mar 03

A Look At Cirralto's (ASX:CRO) CEO Remuneration

Mar 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: SPX 'nin kısa vadeli varlıkları ( A$21.3M ) kısa vadeli yükümlülüklerini ( A$2.5M ) aşıyor.

Uzun Vadeli Yükümlülükler: SPX şirketinin kısa vadeli varlıkları ( A$21.3M ) uzun vadeli yükümlülüklerini ( A$14.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: SPX 'nin net borç/öz sermaye oranı ( 10.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: SPX şirketinin borç/öz sermaye oranı son 5 yılda 0% seviyesinden 38.8% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: SPX şirketinin mevcut serbest nakit akışına göre bir yıldan fazla yetecek nakit pisti bulunmaktadır.

Tahmini Nakit Akışı: SPX un, serbest nakit akışı her yıl % 15.4 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Spenda Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

Spenda (ASX:SPX) Is Using Debt Safely

Is Spenda (ASX:SPX) A Risky Investment?

Is Spenda (ASX:SPX) Using Too Much Debt?

Recent updates

Spenda Limited Announces Howard Digby Steps Down as Non-Executive Director

Spenda Limited (ASX:SPX) completed the acquisition of Limepay Pty Ltd.

Spenda Limited, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2023)

Spenda Limited (ASX:SPX) entered into binding term sheet to acquire Limepay Pty Ltd for AUD 6.65 million.

Spenda Limited Announces Appointment of Andrew Kearnan as A Non-Executive Director

New major risk - Share price stability

Spenda Limited has completed a Follow-on Equity Offering in the amount of AUD 7.175 million.

Spenda Limited Appoints David Laird as Non-Executive and Independent Director

Spenda Limited Appoints David Laird as Non-Executive and Independent Director

Spenda Limited Launches PayFac Services

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.016 loss in FY 2022)

New minor risk - Financial data availability

Here's Why Spenda (ASX:SPX) Can Manage Its Debt Despite Losing Money

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Spenda (ASX:SPX) Is Using Debt Safely

Less than half of directors are independent

Spenda Limited, Annual General Meeting, Nov 25, 2022

Spenda Limited, Annual General Meeting, Nov 25, 2022

Spenda Limited(ASX:SPX) dropped from S&P/ASX Emerging Companies Index

Full year 2022 earnings released: AU$0.016 loss per share (vs AU$0.006 loss in FY 2021)

Is Spenda (ASX:SPX) A Risky Investment?

Less than half of directors are independent

Is Spenda (ASX:SPX) Using Too Much Debt?

MD & Executive Director exercised options to buy AU$367k worth of stock.

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.01 loss in FY 2020)

Cirralto Limited completed the acquisition of Invigo Pty Ltd.

Cirralto Limited (ASX:CRO) agreed to acquire Invigo Pty Ltd for AUD 7 million.

Cirralto Limited (ASX:CRO) completed the acquisition of Appstablishment Software Group Pty Ltd from Rare Air Nominees Pty Ltd.

Independent Chairman exercised options and sold AU$213k worth of stock

A Look At Cirralto's (ASX:CRO) CEO Remuneration

Cirralto Limited Announces Software Release & BPSP/BPA Testing Update

MD & Executive Director exercised options to buy AU$390k worth of stock.

MD & Executive Director recently sold AU$423k worth of stock

Cirralto Limited, Annual General Meeting, Jan 28, 2021

Cirralto Signs BPA Agreement with Fiserv & Mastercard Extending the Company's Business Payments Services

Cirralto Limited Announces the Appointment of Richard Jarvis as Chief Financial Officer, Effective from 1 November 2020

Full year earnings released - AU$0.01 loss per share

Cirralto Limited has completed a Derivatives Offering in the amount of AUD 0.273172 million.

Full year earnings released - AU$0.0048 loss per share

Cirralto Limited announced that it expects to receive AUD 2.712 million in funding

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin